title: Steroids and receptors in canine mammary cancer.
abstract: The aims of this study were to investigate the serum and tissue content of androgens and estrogens in canine inflammatory mammary carcinomas (IMC) as well as in non-inflammatory malignant mammary tumors (MMT), and assessed the immunoexpression of estrogen and androgen receptors using immunohistochemistry. Profiles for the androgens dehydroepiandrosterone (DHEA), androstenedione (A4), and testosterone (T), and for the estrogens 17beta estradiol (E2) and estrone-sulphate (SO4E1) were measured both in tissue homogenates and in serum of MMT and IMC by EIA techniques in 42 non-inflammatory malignant mammary tumors (MMT) and in 14 inflammatory mammary carcinomas (IMC), prospectively collected from 56 female dogs. Androgen receptor (AR) and estrogen receptor alpha (ERalpha) and beta (ERbeta) expression was studied using immunohistochemistry (strepavidin-biotin-peroxidase method) in samples of 32 MMT and 14 IMC, and counted by a computer image analyzer. IMC serum and tissue levels of androgens were significantly higher than MMT levels. Tissue content of estrogens was also significantly higher in IMC than in MMT. Serum values of SO4E1 were significantly higher in IMC, but serum levels of E2 were significantly lower in IMC compared to MMT cases. Medium-high androgen receptor intensity was observed in 64.28% of IMC and 40.62% of MMT. No important differences were found between ERalpha expression in IMC (100% negative) and MMT (90% negative). ERbeta and AR were intensely expressed in highly malignant inflammatory mammary carcinoma cells. To our knowledge, this is the first report relative to AR immunohistochemistry in canine mammary cancer and to estrogens or androgens in serum of dogs with benign or malignant mammary tumors.
authors.affiliation: Department of Animal Physiology, Facultad de Veterinaria, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040 Madrid, Spain. jcillera@vet.ucm.es
authors.forename: Juan C
authors.initials: JC
authors.lastname: Illera
authors.forename: Maria D
authors.initials: MD
authors.lastname: Pérez-Alenza
authors.forename: Ana
authors.initials: A
authors.lastname: Nieto
authors.forename: Maria A
authors.initials: MA
authors.lastname: Jiménez
authors.forename: Gema
authors.initials: G
authors.lastname: Silvan
authors.forename: Susana
authors.initials: S
authors.lastname: Dunner
authors.forename: Laura
authors.initials: L
authors.lastname: Peña
mesh_terms: D000728:Androgens / Q000097:blood / Q000378:metabolism*; D000818:Animals; D004285:Dogs; D004967:Estrogens / Q000097:blood / Q000378:metabolism*; D005260:Female; D007150:Immunohistochemistry; D007249:Inflammation / Q000378:metabolism; D015674:Mammary Neoplasms, Animal / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D011944:Receptors, Androgen / Q000097:blood / Q000276:immunology / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000097:blood / Q000276:immunology / Q000378:metabolism*
chemical_list: D000728:Androgens; D004967:Estrogens; D011944:Receptors, Androgen; D011960:Receptors, Estrogen